ALPHATEC HOLDINGS, INC. Selling, General and Administrative Expense
ALPHATEC HOLDINGS, INC. (ATEC) reported Selling, General and Administrative Expense of $134.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-04
- ALPHATEC HOLDINGS, INC. selling, general and administrative expense for the quarter ending 2026-06-30 was $134.00M, a 13.07% increase year-over-year.
- ALPHATEC HOLDINGS, INC. selling, general and administrative expense for the quarter ending 2026-03-31 was $137.06M, a 7.90% increase year-over-year.
- ALPHATEC HOLDINGS, INC. selling, general and administrative expense for the quarter ending 2025-12-31 was $128.70M, a 12.25% increase year-over-year.
- ALPHATEC HOLDINGS, INC. selling, general and administrative expense for the quarter ending 2025-09-30 was $124.30M, a 13.83% increase year-over-year.
- ALPHATEC HOLDINGS, INC. selling, general and administrative expense for fiscal 2025 was $498.53M, a 10.73% increase from fiscal 2024.
- ALPHATEC HOLDINGS, INC. selling, general and administrative expense for fiscal 2024 was $450.20M, a 20.35% increase from fiscal 2023.
- ALPHATEC HOLDINGS, INC. selling, general and administrative expense for fiscal 2023 was $374.08M, a 24.69% increase from fiscal 2022.
- ALPHATEC HOLDINGS, INC. selling, general and administrative expense for fiscal 2022 was $300.01M, a 30.86% increase from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 9 month as first filed | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $134.00M 10-Q · filed 2026-08-04 | $271.06M 10-Q · filed 2026-08-04 | $399.76M derived: sum of 3 quarters · filed 2026-08-04 | $524.06M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | $137.06M 10-Q · filed 2026-05-05 | $265.76M derived: sum of 2 quarters · filed 2026-05-05 | $390.06M derived: sum of 3 quarters · filed 2026-05-05 | $508.57M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | $128.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $253.00M derived: sum of 2 quarters · filed 2026-02-24 | $371.51M derived: sum of 3 quarters · filed 2026-08-04 | $498.53M 10-K · filed 2026-02-24 | ||||
| 2025-09-30 | $124.30M 10-Q · filed 2025-10-30 | $242.81M derived: sum of 2 quarters · filed 2026-08-04 | $369.83M 10-Q · filed 2025-10-30 | $484.49M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | $118.51M 10-Q · filed 2026-08-04 | $245.52M 10-Q · filed 2026-08-04 | $360.18M derived: sum of 3 quarters · filed 2026-08-04 | $469.38M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | $127.02M 10-Q · filed 2026-05-05 | $241.68M derived: sum of 2 quarters · filed 2026-05-05 | $350.88M derived: sum of 3 quarters · filed 2026-05-05 | $463.61M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $114.66M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $223.86M derived: sum of 2 quarters · filed 2026-02-24 | $336.59M derived: sum of 3 quarters · filed 2026-02-24 | $450.20M 10-K · filed 2026-02-24 | ||||
| 2024-09-30 | $109.20M 10-Q · filed 2025-10-30 | $221.93M derived: sum of 2 quarters · filed 2025-10-30 | $335.54M 10-Q · filed 2025-10-30 | $335.66M 10-Q · filed 2024-10-30 | $439.66M derived: sum of 4 quarters · filed 2026-02-24 | |||
| 2024-06-30 | $112.73M 10-Q · filed 2025-07-31 | $226.34M 10-Q · filed 2025-07-31 | $226.46M 10-Q · filed 2024-07-31 | $330.46M derived: sum of 3 quarters · filed 2026-02-24 | $421.87M derived: sum of 4 quarters · filed 2026-02-24 | |||
| 2024-03-31 | $113.61M 10-Q · filed 2025-05-01 | $113.73M 10-Q · filed 2024-05-07 | $217.73M derived: sum of 2 quarters · filed 2026-02-24 | $309.14M derived: sum of 3 quarters · filed 2026-02-24 | $396.43M derived: sum of 4 quarters · filed 2026-02-24 | |||
| 2023-12-31 | $104.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $195.53M derived: sum of 2 quarters · filed 2026-02-24 | $282.82M derived: sum of 3 quarters · filed 2026-02-24 | $374.08M 10-K · filed 2026-02-24 | ||||
| 2023-09-30 | $91.41M 10-Q · filed 2024-10-30 | $178.70M derived: sum of 2 quarters · filed 2024-10-30 | $269.96M 10-Q · filed 2024-10-30 | $351.88M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2023-06-30 | $87.29M 10-Q · filed 2024-07-31 | $178.55M 10-Q · filed 2024-07-31 | $260.47M derived: sum of 3 quarters · filed 2025-02-26 | $336.42M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2023-03-31 | $91.26M 10-Q · filed 2024-05-07 | $173.18M derived: sum of 2 quarters · filed 2025-02-26 | $249.14M derived: sum of 3 quarters · filed 2025-02-26 | $321.80M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2022-12-31 | $81.92M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $157.87M derived: sum of 2 quarters · filed 2025-02-26 | $230.54M derived: sum of 3 quarters · filed 2025-02-26 | $300.01M 10-K · filed 2025-02-26 | ||||
| 2022-09-30 | $75.95M 10-Q · filed 2023-11-06 | $148.62M derived: sum of 2 quarters · filed 2023-11-06 | $218.09M 10-Q · filed 2023-11-06 | $284.79M derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2022-06-30 | $72.67M 10-Q · filed 2023-08-03 | $142.14M 10-Q · filed 2023-08-03 | $208.83M derived: sum of 3 quarters · filed 2024-02-27 | $270.33M derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2022-03-31 | $69.47M 10-Q · filed 2023-05-04 | $136.16M derived: sum of 2 quarters · filed 2024-02-27 | $197.66M derived: sum of 3 quarters · filed 2024-02-27 | $258.32M derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2021-12-31 | $66.69M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $128.19M derived: sum of 2 quarters · filed 2024-02-27 | $188.85M derived: sum of 3 quarters · filed 2024-02-27 | $229.27M 10-K · filed 2024-02-27 | ||||
| 2021-09-30 | $61.49M 10-Q · filed 2022-11-03 | $122.15M derived: sum of 2 quarters · filed 2022-11-03 | $162.58M 10-Q · filed 2022-11-03 | $202.30M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-06-30 | $60.66M 10-Q · filed 2022-08-04 | $101.08M 10-Q · filed 2022-08-04 | $140.81M derived: sum of 3 quarters · filed 2023-02-28 | $176.19M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-03-31 | $40.43M 10-Q · filed 2022-05-05 | $80.15M derived: sum of 2 quarters · filed 2023-02-28 | $115.53M derived: sum of 3 quarters · filed 2023-02-28 | $142.00M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | $39.73M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $75.11M derived: sum of 2 quarters · filed 2023-02-28 | $101.57M derived: sum of 3 quarters · filed 2023-02-28 | $129.16M 10-K · filed 2023-02-28 | ||||
| 2020-09-30 | $35.38M 10-Q · filed 2021-11-04 | $35.98M 10-Q · filed 2020-11-05 | $61.85M derived: sum of 2 quarters · filed 2021-11-04 | $89.43M 10-Q · filed 2021-11-04 | $91.02M 10-Q · filed 2020-11-05 | $118.41M derived: sum of 4 quarters · filed 2021-11-04 | ||
| 2020-06-30 | $26.47M 10-Q · filed 2021-08-03 | $27.03M 10-Q · filed 2020-08-06 | $54.05M 10-Q · filed 2021-08-03 | $55.04M 10-Q · filed 2020-08-06 | $83.03M derived: sum of 3 quarters · filed 2021-08-03 | $109.98M derived: sum of 4 quarters · filed 2021-08-03 | ||
| 2020-03-31 | $27.58M 10-Q · filed 2021-05-06 | $28.00M 10-Q · filed 2020-05-11 | $56.56M derived: sum of 2 quarters · filed 2021-05-06 | $83.51M derived: sum of 3 quarters · filed 2021-05-06 | $108.20M derived: sum of 4 quarters · filed 2021-05-06 | |||
| 2019-12-31 | $28.98M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05 | $55.93M derived: sum of 2 quarters · filed 2021-03-05 | $80.62M derived: sum of 3 quarters · filed 2021-03-05 | $101.71M 10-K · filed 2021-03-05 | ||||
| 2019-09-30 | $26.95M 10-Q · filed 2020-11-05 | $26.79M 10-Q · filed 2019-11-01 | $51.64M derived: sum of 2 quarters · filed 2020-11-05 | $72.74M 10-Q · filed 2020-11-05 | $72.36M 10-Q · filed 2019-11-01 | $91.75M derived: sum of 4 quarters · filed 2020-11-05 | ||
| 2019-06-30 | $24.69M 10-Q · filed 2020-08-06 | $24.57M 10-Q · filed 2019-07-26 | $45.78M 10-Q · filed 2020-08-06 | $45.57M 10-Q · filed 2019-07-26 | $64.80M derived: sum of 3 quarters · filed 2020-08-06 | $83.63M derived: sum of 4 quarters · filed 2020-08-06 | ||
| 2019-03-31 | $21.10M 10-Q · filed 2020-05-11 | $21.00M 10-Q · filed 2019-05-10 | $40.11M derived: sum of 2 quarters · filed 2020-05-11 | $58.94M derived: sum of 3 quarters · filed 2020-05-11 | $76.48M derived: sum of 4 quarters · filed 2020-05-11 | |||
| 2018-12-31 | $19.01M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17 | $37.84M derived: sum of 2 quarters · filed 2020-03-17 | $55.38M derived: sum of 3 quarters · filed 2020-03-17 | $72.64M 10-K · filed 2020-03-17 | $72.51M 10-K · filed 2019-03-29 | |||
| 2018-09-30 | $18.83M 10-Q · filed 2019-11-01 | $36.37M derived: sum of 2 quarters · filed 2019-11-01 | $53.63M 10-Q · filed 2019-11-01 | |||||
| 2018-06-30 | $17.54M 10-Q · filed 2019-07-26 | $34.80M 10-Q · filed 2019-07-26 | ||||||
| 2018-03-31 | $17.26M 10-Q · filed 2019-05-10 | |||||||
| 2017-12-31 | $69.96M 10-K · filed 2019-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |